Skip to main content
. 2022 Aug 25;15(9):1050. doi: 10.3390/ph15091050

Figure 12.

Figure 12

Anti-proliferative activities (% GI) of compounds 4d, 4e, 4o, and 4p against prostate cancer cell lines.